Anti-αvβ6 antibodies

US7465449B2 · kind B2 · utility

Assignees

• BIOGEN IDEC MA INC. · US
• The Regents of the University of California · US

Inventors

• Shelia M. Violette · Lexington, US
• Paul H. Weinreb · Andover, US
• Kenneth J. Simon · Cambridge, US
• Dean Sheppard · Oakland, US
• Diane R. Leone · Winchester, US

Key dates

• Filing date: Mar 13, 2003
• Grant date: Dec 16, 2008
• Expiry date: Nov 16, 2023

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/205
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Monoclonal antibodies that specifically bind to M.96. Also included are methods of using these antibodies to treat mammals having or at risk of having 006-mediated diseases, or to diagnose % Qmediated diseases.